Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an "Old-fashioned" Drug be Effective?
Hemasphere
.
2023 Mar 27;7(4):e867.
doi: 10.1097/HS9.0000000000000867.
eCollection 2023 Apr.
Authors
Marta Riva
1
,
Alessandro Bosi
2
3
,
Lorenzo Rizzo
1
,
Federico Mazzon
1
3
,
Silvia Ferrari
4
,
Federico Lussana
4
,
Lorenza Borin
5
,
Andrea Castelli
6
,
Roberto Cairoli
1
,
Wilma Barcellini
2
,
Alfredo Molteni
7
,
Bruno Fattizzo
2
3
Affiliations
1
Department of Haematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
2
Haematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
3
Department of Oncology and Haemato-oncology, University of Milan, Italy.
4
Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
5
Department of Hematology, San Gerardo Hospital, Monza, Italy.
6
Haematology, ASL Biella, Italy.
7
Haematology, ASST Cremona, Italy.
PMID:
36999006
PMCID:
PMC10047600
DOI:
10.1097/HS9.0000000000000867
No abstract available